Cargando…

Hypoglycemia associated with off-label sitagliptin use

PURPOSE: To describe a case of hypoglycemia induced by off-label use of sitagliptin in an adult patient with type 2 diabetes. CASE SUMMARY: Addition of sitagliptin to metformin, glimepiride, and NovoLog(®) 70/30 Mix induced hypoglycemia in a 55-year-old Caucasian female. Hypoglycemia improved, altho...

Descripción completa

Detalles Bibliográficos
Autores principales: Whitley, Heather P, Kelley, Kristi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3643046/
https://www.ncbi.nlm.nih.gov/pubmed/23745054
_version_ 1782268254001037312
author Whitley, Heather P
Kelley, Kristi
author_facet Whitley, Heather P
Kelley, Kristi
author_sort Whitley, Heather P
collection PubMed
description PURPOSE: To describe a case of hypoglycemia induced by off-label use of sitagliptin in an adult patient with type 2 diabetes. CASE SUMMARY: Addition of sitagliptin to metformin, glimepiride, and NovoLog(®) 70/30 Mix induced hypoglycemia in a 55-year-old Caucasian female. Hypoglycemia improved, although still occurred periodically, following sulfonylurea discontinuation and a 28% insulin dose reduction. Hypoglycemic symptoms were absent during a 3-day dechallange but occurred again upon sitagliptin reinitiation. DISCUSSION: Although the mechanism of action of sitagliptin does not predispose patients to hypoglycemic events, when combined with hypoglycemia-inducing medications, eg, sulfonylureas or insulin, and possibly meglitinides, the incidence likely increases. CONCLUSIONS: Caution should be used when combining sitagliptin with either sulfonylureas or insulin, and possibly meglitinides, for the treatment of type 2 diabetes as hypoglycemia may ensue. Hypoglycemia due to off-label combinations with insulin and sitagliptin may be prevented by reducing meal-time insulin doses. Prescribers and patients should vigilantly monitor for hypoglycemic events when using sitagliptin off-label with similar pharmacologic combinations such as meglitinides and other rapid-acting insulin products. Additionally, clinicians may encounter resistance from insurance companies to cover such off-label combinations.
format Online
Article
Text
id pubmed-3643046
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-36430462013-06-06 Hypoglycemia associated with off-label sitagliptin use Whitley, Heather P Kelley, Kristi Int Med Case Rep J Case Report PURPOSE: To describe a case of hypoglycemia induced by off-label use of sitagliptin in an adult patient with type 2 diabetes. CASE SUMMARY: Addition of sitagliptin to metformin, glimepiride, and NovoLog(®) 70/30 Mix induced hypoglycemia in a 55-year-old Caucasian female. Hypoglycemia improved, although still occurred periodically, following sulfonylurea discontinuation and a 28% insulin dose reduction. Hypoglycemic symptoms were absent during a 3-day dechallange but occurred again upon sitagliptin reinitiation. DISCUSSION: Although the mechanism of action of sitagliptin does not predispose patients to hypoglycemic events, when combined with hypoglycemia-inducing medications, eg, sulfonylureas or insulin, and possibly meglitinides, the incidence likely increases. CONCLUSIONS: Caution should be used when combining sitagliptin with either sulfonylureas or insulin, and possibly meglitinides, for the treatment of type 2 diabetes as hypoglycemia may ensue. Hypoglycemia due to off-label combinations with insulin and sitagliptin may be prevented by reducing meal-time insulin doses. Prescribers and patients should vigilantly monitor for hypoglycemic events when using sitagliptin off-label with similar pharmacologic combinations such as meglitinides and other rapid-acting insulin products. Additionally, clinicians may encounter resistance from insurance companies to cover such off-label combinations. Dove Medical Press 2008-11-11 /pmc/articles/PMC3643046/ /pubmed/23745054 Text en © 2008 Whitley and Kelley, publisher and licensee Dove Medical Press Ltd. This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited.
spellingShingle Case Report
Whitley, Heather P
Kelley, Kristi
Hypoglycemia associated with off-label sitagliptin use
title Hypoglycemia associated with off-label sitagliptin use
title_full Hypoglycemia associated with off-label sitagliptin use
title_fullStr Hypoglycemia associated with off-label sitagliptin use
title_full_unstemmed Hypoglycemia associated with off-label sitagliptin use
title_short Hypoglycemia associated with off-label sitagliptin use
title_sort hypoglycemia associated with off-label sitagliptin use
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3643046/
https://www.ncbi.nlm.nih.gov/pubmed/23745054
work_keys_str_mv AT whitleyheatherp hypoglycemiaassociatedwithofflabelsitagliptinuse
AT kelleykristi hypoglycemiaassociatedwithofflabelsitagliptinuse